Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Harrow Health, Inc.

Harrow Health, Inc. (HROW) Stock Overview

Explore Harrow Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HROW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$39.25
$0.17(0.44%)
U.S. Market is Open · 13:56

Harrow Health, Inc. (HROW)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio-40.21
EPS (TTM)$0.09
ROE-1.04%
Fundamental Analysis

AI Price Forecasts

1 Month$45.57
3 Months$56.98
1 Year Target$50.17

HROW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Harrow Health, Inc. (NASDAQ: HROW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Harrow Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HROW on the NASDAQ shows an RSI of 45.77, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $50.17 for the NASDAQ listing.

Key metrics behind Harrow Health, Inc.'s NASDAQ-traded stock include a P/E ratio of -40.21 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HROW on the NASDAQ.

Price Performance (NASDAQ: HROW)

1-Day Change
-0.15%
5-Day Change
-1.53%
1-Month Change
-7.34%
3-Month Change
35.58%
6-Month Change
-16.47%
Year-to-Date (YTD) Change
-19.67%
1-Year Change
13.006%
3-Year Change
127.78%
5-Year Change
342.25%
All-Time (Max) Change
53.69%

Contact Information

https://www.harrow.com
615 733 4730
1A Burton Hills Boulevard, Nashville, TN, 37215

Company Facts

3,730 Employees
IPO DateSep 28, 2007
CountryUS
Actively Trading

Frequently Asked Questions